IP Verse

Cytune Pharma opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Cytune Pharma

Patent Number:
EP3601363
Title:
Alt-803 In Combination With Anti-Cd38 Antibody For Cancer Therapies
Applicant:
ALTOR BIOSCIENCE CORPORATION
Opposition Date:
Mar 15, 2023
Patent Number:
EP3263581
Title:
Compositions And Methods For Immunomodulation In An Organism
Applicant:
UNIVERSITY OF CONNECTICUT
Opposition Date:
Aug 4, 2021

Latest patents of Cytune Pharma opposed by its competitors

Patent:
EP3995507
Grant Date:
Oct 4, 2023
Title:
Il-15 And Il-15Ralpha Sushi Domain Based On Modulokines
Oppositions:
1
Patent:
EP2986312
Grant Date:
Dec 15, 2021
Title:
Cytokine Derived Treatment With Reduced Vascular Leak Syndrome
Oppositions:
2
Patent:
EP3444271
Grant Date:
Oct 6, 2021
Title:
Il-15 And Il-15Raplha Sushi Domain Based Modulokines
Oppositions:
2
Patent:
EP3030262
Grant Date:
Oct 9, 2019
Title:
Combined Pharmaceutical Composition
Oppositions:
1
Patent:
EP3030575
Grant Date:
Jul 11, 2018
Title:
Il-15 And Il-15Raplha Sushi Domain Based Modulokines
Oppositions:
1

Competitors of Cytune Pharma

SANOFI

ALTOR BIOSCIENCE CORPORATION

HGF LIMITED

Want to track Cytune Pharma?

Feel free to send us a message here and we will get back to you